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Abstract
BACKGROUND: In the past some authors evaluated FDG-PET
as a powerful tool for non-invasive assessment of malignancy
of solitary pulmonary nodules (SPN). The aim of this paper is to
verify the performance of positron emission tomography with
fludeoxyglucose (FDG-PET) in SPN in the conditions of the
Czech Republic during the first 16 months of the operation of
the PET Centre Prague.
MATERIAL AND METHODS: The group of 22 patients with 23 SPN
was investigated by dedicated PET scanner due to inconclusive
CT scan. Micromorphological confirmation was available in 61%;
follow-up (median = 12 months) concerned the other 39% SPN.
RESULTS: PET was clearly positive in 11 nodules, all were ma-
lignant according to micromorphological assessment. PET was
completely negative in 10 nodules, 3 of them were micromor-
phologically evaluated as benign, the other 7 nodules were fol-
lowed up without any signs of malignancy. In two cases, PET
revealed enhanced glucose consumption, but the pattern was
not typical for malignancy. These cases were considered as
bronchopneumonia, but till now, they have not been definitely
resolved.
CONCLUSIONS: Excluding two unresolved cases, sensitivity and
specificity of FDG-PET was 100% for malignancy in our series.
PET was helpful in medical decision-making in all patients.
Key words: positron emission tomography, PET, FDG,
solitary pulmonary nodules, SPN
Introduction
Solitary pulmonary nodule (SPN) is usually a casual asymp-
tomatic radiological finding on chest radiograph or computed to-
mography (CT). If SPN radiologically appears malignant, open
surgery follows. If SPN has benign radiological characterisation
and the size is unchanged during two-year follow-up, the nodule
is considered definitely benign. Sometimes radiological methods
are limited to distinguishing between benign and malignant le-
sion. In that case micromorphology confirmation is needed by
invasive investigation (transparietal or transbronchial needle bi-
opsy or thoracoscopy or thoracotomy). In general, there are ap-
proximately 2/3 of benign SPN in patients under 35 years of age.
Most malignant SPN are non-small cell lung cancer (NSCLC)
 stage I  with high rate of curability (5080%) [1, 2].
Positron emission tomography with [18F]fludeoxyglucose
(FDG-PET) is a progressive, non-invasive and cost-effective [3]
imaging method for metabolic characterisation of lesions. Malig-
nant cells usually very intensively accumulate FDG, taking advan-
tage in visualisation of malignant nodules as hot spots by PET.
FDG-PET is therefore generally considered as a very sensitive tool
for imaging of malignant lesions. FDG-PET specificity is some-
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times referred lower, because of FDG increased accumulation in
inflammatory and granulomatous lesions.
In the past some authors evaluated FDG-PET as a powerful
tool for non-invasive assessment of malignancy of SPN. The aim
of this paper is to verify performance of FDG-PET in SPN in the
conditions of the Czech Republic and its potential to reduce inva-
sive diagnostical procedure.
Material and methods
Group of patients. From October 1999 to January 2001
a group of 22 patients with 23 SPN was investigated by FDG-PET
due to inconclusive CT scan from the point of view of biological
behaviour of the lesion. The patients (12 men and 10 women,
mean age 60 years) were referred to the PET Centre Prague from
two University Hospitals. Suspicion of SPN originated from chest
plain radiograph in all patients. Reasons for indications for radi-
ography in this series are noted in Table 1.
Diagnostical management. All patients underwent spiral CT
or HRCT scanning. Nodule size ranged from 1 to 6 cm, no lymph
node involvement was apparent on the CT scans. Bronchoscopy
was carried out in 91% (20/22) patients  (1 patient refused, 1 pa-
tient was unable to undergo invasive evaluation). CT-guided transpa-
rietal needle biopsy was carried out in 22% (5/23) SPN, only 3 were
successfully targeted. Surgery was carried out in 48% (11/23) SPN, it
was contraindicated in 18% (4/22) patients. In summary micromor-
phological confirmation was available in 61% (14/23) SPN. Follow-
up (median = 12 months) concerned the other 39% (9/23) SPN.
Method of PET scanning. 65 minutes –14 minutes after intra-
venous administration of 525 MBq 18FDG per 70 kg (body weight cor-
rected) started acquisition in 2D mode of entire torso and neck (57
bed positions) by ECAT EXACT CTI/Siemens PET scanner. Acquisi-
tion of emission data took time for 6.5 min. per bed position. Duration
of hot transmission was 3.56.5 min. per bed position according to
decreasing activity of transmission sources during their 12-month life
-span. Tomographic planes were reconstructed by ECAT 7.2 software
by iterative method OS-EM (6 iteration, 16 subsets, 6 mm Gaussian
filter) and transitory by 7.1 software (1 iteration, 30 subsets), incl. scat-
ter and attenuation correction using segmentation. Only seldom was
filtered back projection without corrections used. Data were visually
assessed by viewing of transaxial, sagittal, coronal slices and volume
rendered data (maximum intensity projections).
Results
PET was clearly positive in 11 nodules. Micromorphological as-
sessment revealed malignant tumour in all these nodules (Table 2).
PET was completely negative in 10 nodules, three of them were
micromorphologically evaluated as benign (tuberculoma, chondro-
hamartoma, angiolipoma). The other seven nodules were followed
up for 12 months (median) without any signs of malignancy.
In two cases, PET revealed enhanced glucose consumption,
but the pattern was not typical for malignancy. One patient had
negative result of transthoracic needle biopsy, both patients had
negative results of bronchoscopy and they are contraindicated for
surgery due to bad cardiopulmonary condition. Till now, they have
not been definitely resolved. Excluding these two patients, sensitiv-
ity and specificity of FDG-PET was 100% in our series (Table 3).
Discussion
PET is referred in the literature as a reliable test for differentiat-
ing benign from malignant SPN with sensitivity and specificity in
the range of 80100%. There are uncommon tumours non-accu-
mulating FDG, such as bronchioloalveolar carcinoma, metastatic
liposarcoma, highly differentiated neuroendocrine tumours, high-
ly fibrotic tumours with a low tumour cell density. These tumours
occasionally diminish sensitivity of PET for identifying malignant
SPN in larger series [2, 46]. In our smaller series two cases of
such tumours (bronchioloalveolar carcinoma, atypical carcinoid)
were present. In contrast to the literature, they avidly accumulated
FDG and did not diminish sensitivity of FDG-PET in our series
(Fig. 1).
Five PET positive nodules were larger then 3 cm. It is easy to
find neoplasm in large nodules for PET [2]. On the other hand,
three PET positive nodules were smaller than 2 cm. The employed
PET scanner has the advantage in small lesion detection in com-
parison to questionable hybrid SPECT/PET coincidence cameras.
Resulting sensitivity should also be considered with respect
to only a 12-month median period of follow-up instead of conven-
tional > 2 years. Probably all these above-mentioned conditions
enabled 100% sensitivity of FDG-PET in our study.
On the other hand, in the literature inflammatory lesions accu-
mulating FDG are referred, e.g. coccidiomycosis, histoplasmo-
sis, cryptococcosis, TBC and other granulomatous diseases [2].
In the Czech Republic the prevalence of these diseases is gener-
ally low. In our series only one tuberculoma was present, more-
over with no FDG consumption. Probably this reason enabled
100% specificity in our study.
Two unresolved patients have chronic obstructive pulmonary
disease with probable bronchopneumonia causing some stripy
uptake of FDG. There is a slow regression on chest radiograph
during 6 months of follow-up.
Conclusions
In situations when anatomical imaging modalities (radiog-
raphy, CT) give ambiguous results, FDG-PET seems to be a very
powerful tool for characterisation of biological behaviour of SPN.
Results achieved during the first 16 months of operation of the
PET Centre Prague (100% sensitivity & specificity) are compa-
rable with published papers at least. Increasing the series of
patients will drop sensitivity & specificity below 100% in the fu-
ture with a high probability. PET was helpful in medical deci-
sion-making in all patients.
Table 1. Characterisation of the group of patients according to the
reasons for chest plain radiograph
Frequency (%) Reason for chest plain radiograph
5.0 Routine preoperative investigation
21.0 Dispensary (risky occupation, other cancer)
32.0 Investigation due to cough, bronchopneumonia
or back pain
42.0 Asymptomatic casual evaluations
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Table 2. Characterisation of nodules
Patient Age Sex Nodule Nodule PET Diagnosis Kind of
number number  size [cm] confirmation
1 46 F 1 ˘ 1.4  Benign tumour Follow-up
2 64 M 2 2.0 · 2.0  Benign tumour Follow-up
3 66 F 3 1.6 · 1.0 + Metastasis of colon carcinoma Histology
4 65 M 4 4.5 · 5.0 + Squamous cell bronchogenic carc. Histology
5 62 F 5 ˘ 2.5  Tuberculoma Histology
6 49 F 6 4.0 · 3.0 + Squamous cell bronchogenic carc. Histology
7 54 F 7 ˘ 1.2  Postinflammatory residuum Follow-up
8 36 M 8 5.3 · 5.7 + BALT lymphoma Histology
9 69 M 9 ˘ 3.5  Chondrohamartoma Histology
10 65 F 10 1.0 · 1.3  Benign tumour Follow-up
11 62 M 11 4.8 · 3.0  Angiolipoma Histology
12 55 F 12 1.9 · 2.4 + Squamous cell bronchogenic carc. Histology
13 56 M 13 N/A  Bronchopneumonia of low regression Follow-up
14 67 F 14 3.3 · 2.4 + Bronchogenic adenocarcinoma Histology
15 67 M 15 ˘ 1.8 + Bronchogenic adenocarcinoma Histology
16 70 F 16 ˘ 2.0  Postinflammatory residuum Follow-up
17 56 M 17 3.0 · 6.0 ? Susp. bronchopneumonia Follow-up
18 54 F 18 2.4 · 2.8 + Bronchogenic adenocarcinoma Histology
19 ˘ 1.0  Postinflammatory residuum Follow-up
19 61 M 20 ˘ 5.7 + Bronchogenic adenocarcinoma Histology
20 52 M 21 2.5 · 2.0 + Atypical carcinoid Histology
21 61 M 22 2.8 · 2.0 + Bronchioloalveolar adenocarcinoma Histology
22 71 M 23 5.0 · 4.0 ? Susp. bronchopneumonia Follow-up
Table 3. Summarised results
MALIGNANT BENIGN UNKNOWN
+ 11 0 0
PET - 0 10 0
? 0 0 2
Figure 1. Interesting case (SPN #22). On the CT (A), SPN is seen in posterior segment of upper right lobe. Nodule of 2.8 x 2.0 cm was non-homoge-
neous with rough margins and pleural reaction. At the PET (B), solitary focus of glucose hypermetabolism is apparent in localisation defined by CT. Of
interest could be bronchoscopy with the only chronic bronchitis bilaterally and negative cytology and histology. Result of following surgery and histo-
pathological assessment was bronchioloalveolar adenocarcinoma pT1N0M0 stage Ia.
Clearly negative by PET is labelled by ; clearly positive is labelled by +; positive
 not typical for malignancy is labelled by ?
Clearly negative by PET is labelled by ; clearly positive is labelled by +; positive  not typical for malignancy is labelled by ?
A B
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